Corona Outbreak on Hormonal Contraceptive Market Size | Share | Industry Forecast Research Report, 2020-2025 | CAGR 3.20%

 Breaking News
  • No posts were found

Corona Outbreak on Hormonal Contraceptive Market Size | Share | Industry Forecast Research Report, 2020-2025 | CAGR 3.20%

August 16
05:39 2020
Corona Outbreak on Hormonal Contraceptive Market Size | Share | Industry Forecast Research Report, 2020-2025 | CAGR 3.20%

Hormonal Contraceptive Market
According to report publish a new market research report on the “Hormonal Contraceptive Market: Global Size, Trends, Competitive, Historical and Forecast Analysis, 2020-2025”

Hormonal Contraceptive Market delivers a succinct analysis on industry size, regional growth and revenue forecasts for the upcoming years. The report further sheds light on significant challenges and latest growth strategies adopted by manufacturers who are a part of the competitive spectrum of this business domain.

Increasing demand to prevent unwanted pregnancy for birth control due the community awareness in making precise decisions relating to generating and sexual health, increasing female population are expected to boost the growth of hormonal Contraceptives market over forecast period

Global Hormonal Contraceptive Market is valued at USD 20.82 Billion in 2018 and expected to reach USD 25.95 Billion by 2025 with the CAGR of 3.20% over the forecast period.

Get Sample Copy of This Premium Report @              

Scope of Global Hormonal Contraceptive Market Reports –

The hormonal contraception products include birth control pill, vaginal ring, contraceptive skin patch and hormone-releasing contraceptive coils. The Hormonal techniques include an implant, an intrauterine device (IUD), injections, pills, a vaginal ring, and a skin patch. These schemes consist of the utilize of hormones that are produced normally by women, such as estrogen and progesterone, to prevent ovulation and in turn pregnancy. However, they do not provide protection against HIV or other sexually transmitted infections. The Contraception entails artificial or deliberate techniques to prevent pregnancy as a consequence of sexual intercourse, by interfering with normal process of ovulation, fertilization, and implantation using barriers, drugs, medical devices or surgical techniques. The Variety of contraceptives such as condoms is used to prevent potential exposure to infection or sexually transmitted diseases. The collective oral contraceptives can increase the risk of certain type of cardiovascular disease in women with a pre-existing condition or already-heightened risk of cardiovascular disease. Smoking metabolic conditions like diabetes, obesity and family history of heart disease are all risk factors which may be exacerbated by the use of certain hormonal contraceptives. The Cervical Chlamydia infections were more frequent in users of hormonal contraception.

The regions covered in this hormonal contraceptive market are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of clinical decision support system is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Hormonal Contraceptive Market Report-

Some major key players for global hormonal contraceptive market are ALLERGAN,Afaxys Inc.,Bayer AG, Agile Therapeutics Inc,Merck and Co., Inc.,Primal Enterprises Ltd.,Pfizer Inc.,HLL Life care Limited, Teva Pharmaceuticals Industries Ltd and Others. 

Global Hormonal Contraceptive Market Segmentation – 

By Product Type

Oral Contraceptive Pills

Vaginal Rings

Emergency Contraceptive Pills

Transdermal Patches

Inject able Birth Control 

By Hormone

Combined Hormonal Contraceptive

Progestin-only Contraceptive 

By End-User




Request for Methodology Report @              


FDA approves five-year hormonal contraceptive

OCTOBER 16, 2018: -Allergan the nonprofit women’s health pharma Medicines360 said has been the FDA approved an application to extend the duration of use for Liletta for the prevention of pregnancy for up to five years. Hence, the Medicines360 first won approval for the Levonorgestrel-releasing intrauterine device in February of 2015. The latest system FDA approval is based on a review of additional efficacy and safety data from an ongoing Phase III trial. The access IUS trial, which includes 1,751 women across the U.S., found that Liletta is more than 99% effective in preventing pregnancy for up to five years in a range of women. However, the large and diverse population of women already uses Liletta as a safe, long-acting and reversible contraceptive option. However, the approval means that Liletta is now indicated for up to 5 years of use. To date, no hormonal IUD has been studied across more women in a single Phase III clinical trial conducted in the U.S.,” Dr. Jessica Grossman, CEO of Medicines360, said in prepared remarks. The partnership with Allergan, we remain steadfast in our mission to help women access available birth control methods that are appropriate for them, regardless of their income. 

Global Hormonal Contraceptive Market Dynamics 

The rapidly increasing cost of living, technological advancements, increasing development of effective female contraceptive drugs and devices, rise global prevalence of sexually transmitted infections (STI) in low income countries, rise in adoption of permanent contraceptive practices instead of crucial family planning is trending the hormonal contraceptives market. According to the World Health Organization (WHO), around 12.8 million of girls aged 15-19 gives birth before reproductive age every year representing 44 births per 1000 adolescent girls in this age group who ultimately need hormonal Contraceptives therapy propelling the growth of this market. However, the side effects associated with temporary or permanent contraception and rising prevalence of sterility rates are restraining growth of the market. The recent growth of this market are urbanization and increased awareness about hormonal contraception and the policies setup by the government to promote hormonal contraception. Additionally, the contraceptive technique that is safe, effective, and acceptable within the cultural, social, religious, and ethical frameworks of individuals and societies would have a significant positive effect on human well-being different than most other products whose development is regulated by the actions of the marketplace, the development of new contraceptives is influenced by often conflicting and uncoordinated public policies. Hence, the impact of these policies, together with other aspects of contraceptive crop, such as the complexity of evaluating their risks and profit& the importance of the social benefits of contraceptive, number of methods currently available has slowed the development of new methods.

Global Hormonal Contraceptive Market Regional Analysis –

North America is dominating the market due to highest market share in terms of profits in overall market of hormonal contraceptives service across the global due to increasing investments in research and development activities for the discovery of new formulation and products. The North America market holds major value share in the global footprint followed by Europe due to high awareness of people about population control, prevalence of infertility and high adoption of contraceptive crop. The Asia Pacific region is expected to lead the global Hormonal Contraceptives market by the end of the forecast period. However, few rural areas, and cultural and religious opposition in certain emerging countries, such as China, India, Thailand, Vietnam, Malaysia, and Philippines, hinder the market growth. The emerging markets have a high potential to grow owing to the maximum proportion of young women who need to use modern contraceptives methods. Further, the government is focusing toward improvising healthcare infrastructure and creating awareness among people for early prevention of unintended pregnancies. According to the World Health Organization (WHO) in 2015, the substantial gaps still persist in the use of modern methods among couples who want to prevent pregnancy, in the less than half of total demand for family planning was being met with modern methods in 54 countries In an additional 76 countries, less than 75 % of total demand was met by use of modern technique in Asia Pacific.

Table of Contents

1. Chapter – Report Methodology

1.1. Research Process

1.2. Primary Research

1.3. Secondary Research

1.4. Market Size Estimates

1.5. Data Triangulation

1.6. Forecast Model

1.7. USP’s of Report

1.8. Report Description 

2. Chapter – Global Hormonal Contraceptive Market Overview: Qualitative Analysis

2.1. Market Introduction

2.2. Executive Summary

2.3. Global Hormonal Contraceptive Market Classification

2.4. Market Drivers

2.5. Market Restraints

2.6. Market Opportunity

2.7. Hormonal Contraceptive Market: Trends

2.8. Porter’s Five Forces Analysis

2.9. Market Attractiveness Analysis 

3. Chapter – Global Hormonal Contraceptive Market Overview: Quantitative Analysis

4. Chapter – Global Hormonal Contraceptive Market Analysis: Segmentation By Type

5. Chapter – Global Hormonal Contraceptive Market Analysis: Segmentation By Application


Buy Detail Report @

About Us:

We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.

Media Contact
Company Name: Brandessence Market Research and Consulting Pvt ltd.
Contact Person: Alan
Email: Send Email
Phone: +917447409162
Address:Office No 101 City Point, Survey No. 171/9, Bhekrai Nagar, Near HP Petrol Pump, Opp. HDFC bank Hadapsar-Saswad Road
City: Pune
State: Maharashtra
Country: India